We value your privacy
We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.
Clinical Trials
5
2 active
Approvals
0
Total approvals
Agencies
Regulatory bodies
Founded
N/A
Active, not recruiting
1
20.0%
Completed
2
40.0%
Not yet recruiting
Recruiting
No approval data available
- Ireland has initiated MAGIC-I (Molecular and Genomic Interrogation of Childhood Cancer – Ireland), the country's first clinical genomics study in pediatric oncology, aiming to optimize treatment through advanced genetic profiling. - The five-year project will establish processes for comprehensive genomic analysis for all children and adolescents with cancer in Ireland, potentially enabling earlier diagnosis and personalized treatment approaches. - Developed through collaboration between Systems Biology Ireland, Children's Health Ireland, Precision Oncology Ireland, and industry partners, the study incorporates innovative concepts like digital twins and computational modeling.
